Add to ORKGLeft ventricular assist devices (LVAD) improve survival in patients with advanced heart failure but are prone to various complications causing mechanical failure. Inflow cannula stenosis presents a particular challenge often requiring invasive surgical repair. We present a novel transcatheter approach for stent delivery to successfully restore hemodynamic function in a patient with inflow cannula stenosis of a HeartMate II LVAD. © 2017 Wiley Periodicals, Inc
DisclosureThis presentation describes the off-label use of the Centrimag™ Ventricular Assist Device ...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
Even in the era of percutaneous reperfusion therapy, left ventricular (LV) remodeling after myocardi...
Left ventricular assist devices (LVAD) improve survival in patients with advanced heart failure but ...
Left Ventricular Assist Devices (LVADs) are becoming a more widely accepted form of treatment for pa...
Cardiovascular diseases are a leading cause of death throughout the developed world. With the demand...
Congestive heart failure is the leading cause of hospitalization and death in the developed world an...
End-stage heart failure is more often treated with Implantable left ventricular assist device (LVAD)...
Transcatheter implantation of balloon expandable valves in native mitral valves (MV) has been perfor...
Left ventricular assist device (LVAD) therapy is a well accepted and effective strategy to treat adv...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
As the incidence of heart failure rises and given the shortage of donor organs, left ventricular ass...
We describe three successful cases of HeartMate(R)left ventricular assist device (LVAD; Thermo Cardi...
In the UK, death from heart failure (HF) is at 24,000 in 2001, while new cases of HF is estimated to...
Recent outstanding clinical advances with new mechanical circulatory systems have led to additional ...
DisclosureThis presentation describes the off-label use of the Centrimag™ Ventricular Assist Device ...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
Even in the era of percutaneous reperfusion therapy, left ventricular (LV) remodeling after myocardi...
Left ventricular assist devices (LVAD) improve survival in patients with advanced heart failure but ...
Left Ventricular Assist Devices (LVADs) are becoming a more widely accepted form of treatment for pa...
Cardiovascular diseases are a leading cause of death throughout the developed world. With the demand...
Congestive heart failure is the leading cause of hospitalization and death in the developed world an...
End-stage heart failure is more often treated with Implantable left ventricular assist device (LVAD)...
Transcatheter implantation of balloon expandable valves in native mitral valves (MV) has been perfor...
Left ventricular assist device (LVAD) therapy is a well accepted and effective strategy to treat adv...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
As the incidence of heart failure rises and given the shortage of donor organs, left ventricular ass...
We describe three successful cases of HeartMate(R)left ventricular assist device (LVAD; Thermo Cardi...
In the UK, death from heart failure (HF) is at 24,000 in 2001, while new cases of HF is estimated to...
Recent outstanding clinical advances with new mechanical circulatory systems have led to additional ...
DisclosureThis presentation describes the off-label use of the Centrimag™ Ventricular Assist Device ...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
Even in the era of percutaneous reperfusion therapy, left ventricular (LV) remodeling after myocardi...